Hoshi Iryo-Sanki Co., Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Hoshi Iryo-Sanki Co., Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 64% of its market value (net cash). Higher than 97% of Healthcare companies in Japan.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.0 times. Higher than 92% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥167Over the last 3 years, every ¥100 of reported profit came with ¥167 of operating cash.
Higher than 76% of Healthcare companies in Japan.
Self-Funding Ratio
6.0×Over the last 3 years its own operating cash covered its investment spending (capex) 6.0 times.
Higher than 92% of Healthcare companies in Japan.
Cash Locked Ratio
¥1For every ¥100 of sales, ¥1 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥1 tied up three years earlier.
Less money tied up than 81% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 71% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥7Sales grew 13% in 3 years; of every extra ¥100 of sales, ¥7 became extra profit.
Higher than 54% of Healthcare companies in Japan.
Asset Productivity Ratio
+13% / +26%In 3 years sales changed by +13% while total assets changed by +26%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
3.7×Debt due within a year is covered 3.7 times by its yearly operating cash.
Higher than 79% of Healthcare companies in Japan.
Cash Cushion Ratio
+64%Cash, after subtracting all debt, equals 64% of its market value (net cash).
Higher than 97% of Healthcare companies in Japan.
Tangible Assets Ratio
99%Of every ¥100 the company owns, ¥99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 78% of Healthcare companies in Japan.
Tangible Net Worth Ratio
99%Of every ¥100 of net worth, ¥99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 81% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Hoshi Iryo-Sanki Co., Ltd. owes ¥0.24 for every ¥1 it owns. Net profit fell 6% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
11.2Investors pay ¥11.2 for every ¥1 of Hoshi Iryo-Sanki Co., Ltd.'s yearly profit, lower than 77% of Healthcare companies in Japan.
P/B ratio
0.78The share price is 0.78 times Hoshi Iryo-Sanki Co., Ltd.'s book value per share, lower than 88% of Healthcare companies in Japan.
Market cap
¥15.6 BThe total market value of all of Hoshi Iryo-Sanki Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 51% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥20.0 BWhat Hoshi Iryo-Sanki Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥6,402Net worth divided by the number of shares. The share price of ¥4,985 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
7.1%Hoshi Iryo-Sanki Co., Ltd. earned 7.1% on its shareholders' money over the last year, lower than 51% of Healthcare companies in Japan.
Owes vs Owns
0.24×Hoshi Iryo-Sanki Co., Ltd. owes ¥0.24 for every ¥1 it owns (low), lower than 69% of Healthcare companies in Japan.
Dividend yield
1.81%Hoshi Iryo-Sanki Co., Ltd. pays 1.81% of its share price as dividends a year, lower than 76% of dividend-paying Healthcare companies in Japan.
Revenue growth
+3%Revenue rose 3% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Profit growth
-6%Net profit fell 6% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Profit margin
8.8%Hoshi Iryo-Sanki Co., Ltd. keeps ¥9 of every ¥100 of revenue as net profit.
Cash quality
1.8×Cash from Hoshi Iryo-Sanki Co., Ltd.'s business was 1.8× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
105.0×Hoshi Iryo-Sanki Co., Ltd.'s operating profit covered its interest costs 105.0 times in the year to Mar 2026.
Cash vs debt
Net cashHoshi Iryo-Sanki Co., Ltd. held ¥9.9 B more cash than debt (net cash) at Mar 2026.
Questions
What is Hoshi Iryo-Sanki Co., Ltd.'s P/E ratio?
Investors pay ¥11.2 for every ¥1 of Hoshi Iryo-Sanki Co., Ltd.'s yearly profit, lower than 77% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Hoshi Iryo-Sanki Co., Ltd.: ¥15.6 B ÷ ¥20.0 B (31 Mar 2026) = 0.8.
What is Hoshi Iryo-Sanki Co., Ltd.'s return on equity?
Hoshi Iryo-Sanki Co., Ltd. earned 7.1% on its shareholders' money over the last year, lower than 51% of Healthcare companies in Japan.
How much does Hoshi Iryo-Sanki Co., Ltd. owe compared with what it owns?
Hoshi Iryo-Sanki Co., Ltd. owes ¥0.24 for every ¥1 it owns (low), lower than 69% of Healthcare companies in Japan.
Does Hoshi Iryo-Sanki Co., Ltd. pay a dividend?
Yes. Hoshi Iryo-Sanki Co., Ltd. pays 1.81% of its share price as dividends a year, lower than 76% of dividend-paying Healthcare companies in Japan.
Is Hoshi Iryo-Sanki Co., Ltd.'s revenue growing?
Revenue rose 3% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.